Agilent Has Built an Annuity on Merck’s Clinical Programme, One Indication at a Time
Agilent won its eighth CE-marked companion diagnostic indication for a single PD-L1 assay, each one riding on a label expansion Merck paid to generate.
The Pulse
The Signal
No post found!
No post found!
No post found!
NeuroPulse
No post found!
No post found!
Deal Room
No post found!
No post found!
Access Watch
What’s Next
A Company Called StrokeDx Just Cleared a Device That Is Not Cleared to Detect Stroke
Dassault Paid $1.8B Cash for the Company That Processes 12 Million Safety Reports a Year
Trump Wants Generics Made in America by 2028. The Economics Say They Can’t.
